Budesonide 21-acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

67 API Suppliers, 24 USDMF, 28 CEP/COS, 7 JDMF, 7 EU WC, 15 KDMF, 34 NDC API, 43 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

INTERMEDIATES

7 Intermediates Suppliers

7 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

611 FDF Dossiers, 54 FDA Orange Book, 429 Europe, 23 Canada, 13 Australia, 39 South Africa, 53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 2 Seqens, 9 DKSH, 1 Jai Radhe Sales, 4 Faran Shimi Pharmaceutical, 10 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

67 Coating Systems & Additives, 67 Fillers, Diluents & Binders, 41 Controlled & Modified Release, 33 Thickeners and Stabilizers, 30 Direct Compression, 24 Solubilizers, 20 Film Formers & Plasticizers, 20 Granulation, 19 Lubricants & Glidants, 19 Taste Masking, 18 Topical, 15 Parenteral, 15 Co-Processed Excipients, 11 Disintegrants & Superdisintegrants, 9 Emulsifying Agents, 9 Empty Capsules, 6 Rheology Modifiers, 6 Chewable & Orodispersible Aids, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 129 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 232 Finished Drug Prices, 37 Annual Reports

MARKET PLACE

18 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

53 US Patents, 5 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 13 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 205613 / DOSAGE - AEROSOL, FOAM;RECTAL - 2MG/ACTUATION

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BUDESONIDE(UNII: Q3OKS62Q6X) (BUDESONIDE - UNII:Q3OKS62Q6X)	BUDESONIDE	28mg

Inactive Ingredients

Ingredient Name	Oceanside Pharmaceuticals	Salix Pharmaceuticals, Inc.
BUTANE(6LV4FOR43R)
CETOSTEARYL ALCOHOL(2DMT128M1S)
CETYL ALCOHOL(936JST6JCN)
CITRIC ACID MONOHYDRATE(2968PHW8QP)
EDETATE DISODIUM(7FLD91C86K)
ISOBUTANE(BXR49TP611)
POLYSORBATE 60(CAL22UVI4M)
PROPANE(T75W9911L6)
PROPYLENE GLYCOL(6DC9Q167V3)
STEARETH-10(FD0913P475)
WATER(059QF0KO0R)

Drug Product Composition: Budesonide 21-acetate